Morgan Stanley Portfolio holdings
Morgan Stanley, founded in 1935 by Henry Sturgis Morgan and Harold Stanley as a spin-off from J.P. Morgan & Co., is a leading global financial services firm headquartered in New York City. Initially focused on investment banking, it has evolved into a diversified powerhouse offering wealth management, institutional securities, and asset management services, catering to corporations, governments, institutions, and high-net-worth individuals. With a strong presence in mergers and acquisitions, underwriting, and trading, Morgan Stanley manages billions in assets and is known for its sophisticated financial advisory services. The firm has adapted to modern markets by expanding its digital offerings and wealth management division, notably through its 2020 acquisition of E*TRADE, solidifying its position as a Wall Street titan.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Intuitive Surgical
ISRG
|
+$828M |
| 2 |
Invesco QQQ Trust
QQQ
|
+$788M |
| 3 |
Qualcomm
QCOM
|
+$771M |
| 4 |
Apple
AAPL
|
+$719M |
| 5 |
Baxter International
BAX
|
+$571M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.57B |
| 2 |
Wells Fargo
WFC
|
+$967M |
| 3 |
KKR & Co
KKR
|
+$455M |
| 4 |
Booking.com
BKNG
|
+$401M |
| 5 |
GGP
GGP Inc.
GGP
|
+$384M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 29.32% |
| 2 | Technology | 13.38% |
| 3 | Healthcare | 9.68% |
| 4 | Financials | 9.31% |
| 5 | Consumer Discretionary | 8.04% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
101
3M
MMM
$82.5B
| $852M | 0.21% |
4,835,313
+514,593
| +12% | +$88.6M |
2013 Q2
21 quarters
|
|
102
Vanguard Short-Term Corporate Bond ETF
VCSH
$44.2B
| $836M | 0.21% |
10,699,681
+153,575
| +1% | +$12M |
2013 Q2
21 quarters
|
|
103
Bristol-Myers Squibb
BMY
$121B
| $830M | 0.21% |
13,367,440
+2,202,177
| +20% | +$131M |
2013 Q2
21 quarters
|
|
|
104
Baxter International
BAX
$12.6B
| $815M | 0.2% |
10,570,520
+7,697,267
| +268% | +$571M |
2013 Q2
21 quarters
|
|
105
EPAM Systems
EPAM
$5.84B
| $798M | 0.2% |
5,793,689
+388,438
| +7% | +$52.3M |
2013 Q2
21 quarters
|
|
106
Medtronic
MDT
$113B
| $797M | 0.2% |
8,105,990
-223,855
| -3% | -$20.7M |
2013 Q2
21 quarters
|
|
|
RDS.A
107
DELISTED
Royal Dutch Shell PLC ADS Class A
RDS.A
| $789M | 0.2% |
11,572,390
-555,746
| -5% | -$37.1M |
2013 Q2
21 quarters
|
|
108
DexCom
DXCM
$31.7B
| $784M | 0.2% |
21,913,200
+1,797,704
| +9% | +$55.7M |
2013 Q2
21 quarters
|
|
109
PIMCO Enhanced Short Maturity Active Exchange-Traded Fund
MINT
$18.3B
| $771M | 0.19% |
7,588,201
+818,054
| +12% | +$83M |
2013 Q2
21 quarters
|
|
|
TFCF
110
DELISTED
Twenty-First Century Fox, Inc. Class B
TFCF
| $759M | 0.19% |
16,558,691
+95,137
| +0.6% | +$4.31M |
2013 Q3
20 quarters
|
|
111
iShares TIPS Bond ETF
TIP
$14.2B
| $750M | 0.19% |
6,777,338
+46,402
| +0.7% | +$5.18M |
2013 Q2
21 quarters
|
|
112
Invesco S&P 500 Equal Weight ETF
RSP
$97.5B
| $746M | 0.19% |
6,986,305
-7,745
| -0.1% | -$818K |
2013 Q2
21 quarters
|
|
113
Blackrock
BLK
$168B
| $743M | 0.19% |
1,577,086
-1,649
| -0.1% | -$802K |
2013 Q2
21 quarters
|
|
114
Vanguard Dividend Appreciation ETF
VIG
$111B
| $734M | 0.18% |
6,634,317
+236,358
| +4% | +$25.4M |
2013 Q2
21 quarters
|
|
115
State Street Health Care Select Sector SPDR ETF
XLV
$43.9B
| $732M | 0.18% |
7,691,407
+1,409,812
| +22% | +$127M |
2013 Q2
21 quarters
|
|
116
Goldman Sachs
GS
$261B
| $730M | 0.18% |
3,257,484
+52,899
| +2% | +$12.3M |
2013 Q2
21 quarters
|
|
117
Becton Dickinson
BDX
$50.1B
| $723M | 0.18% |
2,840,551
+1,621,375
| +133% | +$399M |
2013 Q2
21 quarters
|
|
118
Spotify
SPOT
$109B
| $717M | 0.18% |
3,963,794
+2,263,937
| +133% | +$415M |
2018 Q2
1 quarter
|
|
119
iShares Russell 2000 Growth ETF
IWO
$14.1B
| $715M | 0.18% |
3,324,683
+80,349
| +2% | +$17.1M |
2013 Q2
21 quarters
|
|
120
Vulcan Materials
VMC
$31.7B
| $714M | 0.18% |
6,423,074
+303,986
| +5% | +$35.3M |
2013 Q2
21 quarters
|
|
121
CVS Health
CVS
$110B
| $710M | 0.18% |
9,018,238
+659,975
| +8% | +$47.2M |
2013 Q2
21 quarters
|
|
122
NVIDIA
NVDA
$5.54T
| $699M | 0.18% |
99,509,520
-11,580,480
| -10% | -$75.3M |
2013 Q2
21 quarters
|
|
123
State Street SPDR S&P Biotech ETF
XBI
$10B
| $696M | 0.17% |
7,260,363
-2,308,476
| -24% | -$224M |
2013 Q2
21 quarters
|
|
124
Vanguard Morningstar Small-Cap ETF
VB
$78.1B
| $688M | 0.17% |
4,232,227
-348,001
| -8% | -$56.3M |
2013 Q2
21 quarters
|
|
125
Vanguard Real Estate ETF
VNQ
$35.8B
| $688M | 0.17% |
8,527,512
+16,968
| +0.2% | +$1.4M |
2013 Q2
21 quarters
|
|
Similar funds
Morgan Stanley's Q3 2018 Portfolio in Review
As of Q3 2018, Morgan Stanley held 7,051 positions worth $400B, up 7.9% from $370B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Morgan Stanley's Q3 2018 filing shows 207 new, 2,867 increased, 3,205 reduced and 166 closed positions. Its largest new stake was Elanco Animal Health: 9,012,591 shares worth $314M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $1.57B.
By sector, the portfolio is most concentrated in Miscellaneous at 29% of assets, down from 30% a quarter earlier, followed by Technology and Healthcare.
- Morgan Stanley's largest Q3 2018 buy was Elanco Animal Health: 9,012,591 shares worth $314M.
- Morgan Stanley added most to Intuitive Surgical in Q3 2018, an estimated $828M increase.
- Morgan Stanley's biggest Q3 2018 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.57B.
- Morgan Stanley fully exited GGP Inc. in Q3 2018, selling an estimated $384M.
- Morgan Stanley's ten largest holdings make up 15% of its $400B portfolio in Q3 2018.
- Morgan Stanley opened 207 new positions and closed 166 in Q3 2018.
- Morgan Stanley's portfolio value rose 7.9% quarter-over-quarter to $400B.
Based on Morgan Stanley's 13F filing for Q3 2018, filed 14 Nov 2018.